Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker

Ophthalmologica

Volumn 212, Issue 6, 1998, Pages 410-414

  Armstrong, Donald ^a   Augustin, Albert J ^b   Spengler, Robert ^a   Al Jada, Ahmad ^a   Nickola, Tracy ^a   Grus, Franz ^b   Koch, Frank ^c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF BONN   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Diabetes; Macular pucker; Proliferative vitreoretinopathy; Tumor necrosis factor ; Vascular endothelial growth factor

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; PROLIFERATIVE RETINOPATHY; TISSUE LEVEL; VITREORETINOPATHY;

DIABETIC RETINOPATHY; ENDOTHELIAL GROWTH FACTORS; EPIRETINAL MEMBRANE; HUMANS; LASER COAGULATION; LYMPHOKINES; MACULA LUTEA; OSMOLAR CONCENTRATION; RETINAL DISEASES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE;

EID: 0031712272     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000027378     Document Type: Article

References (36)

1. Peer T, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E: Hypoxia-induced expression of vascular endothelial growth factor by retinal cells in a common factor in neovascularizing ocular disease. Lab Invest 1995;72:638-645.
2. Stone J, Itin A, Peer AT, Gnessin H, Chanling T, Keshet E: Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neurologia. J Neurosci 1995;15:4738-4747.
3. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal diseases. N Engl J Med 1994;331:1480-1487.
4. Aiello LP, Northrop JM, Keyt BA, Takagi H, Iwamoto MA: Hypoxia regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995;113:1538-1544.
5. Pournaras CJ: Retinal oxygen distribution: Its role in the physiopathology of vasoproliferative microangiopathies. Retina 1995;15:332-347.
6. Armstrong D, Abdella N, Salman A, Miller N, Abdel-Rahman E, Bojanczyk M: Relationships of lipid peroxides to complications: Comparison with conventional laboratory test. J Diabetes Complications 1992;6:116-122.
7. Gallou G, Ruelland A, Legras B, Maugendre D, Allannic H, Cloarec L: Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clin Chim Acta 1993;214:227-234.
8. Augustin AJ, Breipohl W, Boker T, Spitznas M: Increased lipidperoxide levels and myeloperoxidase activity in the vitreous of patients suffering from proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 1993;231: 647-650.
9. Böker T, Augustin AJ, Breipohl W, Lutz J, Spitznas M: Increased lipid peroxide level and myeloperoxidase activity in the vitreous of patients suffering from proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 1994;232:652-656.
10. Ignatowski T, Spengler R: Tumor necrosis factor alpha: Presynaptic sensitivity is modified after antidepressant drug administration. Brain Res 1994;665:293-299.
11. Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW: Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with non-proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1997;38:36-47.
12. Limb GA, Chignell AH, Woon H, Green W, Cole CJ, Dumonde DC: Evidence of chronic inflammation in retina excised after relaxing retinotomy for anterior proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 1996;234:213-220.
13. Kliffen M, Sharma HS, Mooy CM, Kerkvliet S, de Jong PTVM: Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol 1997;81:154-162.
14. Kutty RK, Kutty G, Hooks JJ, Wiggert B, Naginneni CN: Transforming growth factor beta inhibits the cytokine-mediated expression of the inducible nitric oxide synthase mRNA in human retinal pigment epithelial cells. Biochem Biophys Res Commun 1995;215:386-393.
15. Platts KE, Benson MT, Rennie IG, Sharrad RM, Rees RC: Cytokine modulation of adhesion molecule expression on human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1995;36:2262-2269.
16. Chung M, Taba K, Casella AMB, Spee C, Hinton DR, Ryan SJ: Tumor necrosis factor alpha (TNF-α) stimulates migration of human retinal pigment epithelial cells (RPE) in vitro (abstract). Invest Ophthalmol Vis Sci 1997;38: S671.
17. Thieme H, Aiello LP, Takagi H, Ferrara N, King GL: Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes 1995;44: 98-103.
18. Tang S, Le-Ruppert KC, Gabel V-P: Proliferation and activation of vascular endothelial cells in epiretinal membranes from patients with proliferative diabetic retinopathy. Ger J Ophthalmol 1994;3:131-136.
19. Michelson IC: The mode of development of the vascular system of the retina with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK 1948;68: 137-148.
20. Malecaze F, Clamens S, Simorre-Pinatel V, Mathis A, Chollet P, Farvard C, Bayard F, Plouet J: Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol 1994;112: 1476-1482.
21. Foreman D, Williams G, Boulton ME, McLeod D: VEGF distribution in proliferative diabetic retinopathy (abstract). Invest Ophthalmol Vis Sci 1996;37:5973.
22. Tanaka Y, Kitano S, Hori S, Kato S, Fumatsu H, Miura M, Yamasita T, Yamamoto T, Yamashita H: Correlation between vascular endothelial growth factor (VEGF) and retinopathy progression in diabetic patients (abstract). Invest Ophthalmol Vis Sci 1996;37:5792.
23. Shima D, Adamis A, Ferrara N, Yeo K, Allende R, Folkman J, D'Amore P: Hypoxic induction of endothelial growth factors in retinal cells: Identification and characterization of vascular endothelial growth factor as the mitogen. Mol Med 1995;1:182-193.
24. Hashimoto E, Ogita T, Nakaoka T, Matsuoka R, Takao A, Kira Y: Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol 1994; 36:H1948-H1954.
25. Augustin AJ, Spitznas M, Koch F, Grus F, Böker T: Indicators of oxidative tissue damage and inflammatory activity in epiretinal membranes of proliferative diabetic retinopathy (PDR), proliferative vitreoretinopathy (PVR) and macular pucker (MP). Ger J Ophthalmol 1995;4:47-51.
26. Kelly J: Cytokines and lung. Am Rev Respir Dis 1990;141:765-788.
27. Larrick J, Kunkel S: The role of tumor necrosis factor and interleukin-1 in the immunoinflammatory response. Pharm Res 1988;5:129-139.
28. Ellner SG, Strieter RM, Elner VM, Rollins BJ, Del Monte MA, Kunkel SL: Monocyte chemotactic protein gene expression by cytokine-treated human retinal pigment epithelial cells. Lav Invest 1991;64:819-825.
29. Vaddi K, Nicolini FA, Mehta P, Mehta JL: Increased secretion of tumor necrosis factor alpha and interferon gamma by mononuclear leukocytes in patients with ischemic heart diseases. Circulation 1994;90:694-699.
30. Kauffmann DJH, van Meurs JC, Mertens DAE, Peperkamp E, Master C, Gerritsen ME: Cytokines in vitreous humor: Interleukin-6 is elevated in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1994;35:900-906.
31. Limb GA, Little BC, Meager A, Ogilvie JA, Wolstencroft RA, Franks WA, Chignell AN, Dumonde DC: Cytokines in proliferative vitreoretinopathy. Eye 1991;5:686-693.
32. Yoshimura N, Matsumoto M, Shimizu H, Mandai M, Hata Y, Ishibashi T: Photocoagulated human retinal pigment epithelial cells produce an inhibitor of vascular endothelial cell proliferation. Invest Ophthalmol Vis Sci 1995;36: 1686-1691.
33. Koolwijk P, Vanerck MGM, Devree WJA, Vermeer M, Weich HA, Hanemaaijer R, Vanhinsberg VWM: Cooperative effect of TNF-α, bFGF and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix - Role of urokinase activity. J Cell Biol 1996;132:1177-1188.
34. Frank S, Hubner G, Breier G, Longaker M, Greenhalgh D, Werner S: Regulation of vascular endothelial growth factor expression in cultured keratinocytes - Implications for normal and impaired wound healing. J Biol Chem 1995;270:12607-12613.
35. Frater-Schroder M, Risau W, Hallmann R, Gautoschi P, Bohlen P: Tumor necrosis factor type a, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 1987;84:5277-5281.
36. Moreau T, Coles A, Wing M, Issacs J, Hale G, Waldmann H, Compston A: Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain 1996; 119:225-237.